Literature DB >> 444352

Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.

S H Curry, R Whelpton, P J de Schepper, S Vranckx, A A Schiff.   

Abstract

1 Fluphenazine (1,2-ethanol 14C) was administered to seven human subjects as the dihydrochloride and as the enanthate and decanoate esters. 2 The subjects had previously been treated with fluphenazine injections for at least 6 months. 3 Fluphenazine was separated from its radioactive metabolites by selective solvent extraction. Plasma concentrations were measured for up to 21 days after dosing. 4 The preparations showed differences in peak concentrations, times of the peaks and half-times of the elimination phase. The longest half-times occurred with the decanoate and the shortest with the dihydrochloride. 5 It is postulated that the differences in kinetics relate principally to the release of the compound from the site of injection. 6 There was no evidence for presence of the esters in plasma, urine or faeces.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 444352      PMCID: PMC1429660          DOI: 10.1111/j.1365-2125.1979.tb00941.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Determination of fluphenazine in plasma by ion-pair partition chromatography.

Authors:  R Johansson; K O Borg; M Gabrielsson
Journal:  Acta Pharm Suec       Date:  1976

2.  Double-blind trial of fluphenazine decanoate.

Authors:  S H Curry; L Adamson
Journal:  Lancet       Date:  1972-09-09       Impact factor: 79.321

3.  Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine.

Authors:  L Adamson; S H Curry; P K Bridges; A F Firestone; N I Lavin; D M Lewis; R D Watson; C M Xavier; J A Anderson
Journal:  Dis Nerv Syst       Date:  1973 Apr-May

4.  The problem of clinical activity of long-acting neuroleptics.

Authors:  A B Smulevitch; E I Minsker; N A Mazayeva; R P Volkova; S K Lukanina
Journal:  Compr Psychiatry       Date:  1973 May-Jun       Impact factor: 3.735

5.  Determination of perphenazine and fluphenazine in whole blood by gas chromatography.

Authors:  N E Larsen; J Naestoft
Journal:  Med Lab Technol       Date:  1973-04

6.  [Metabolic studies with long-acting compounds].

Authors:  E C Schreiber; M L Grozier
Journal:  Therapie       Date:  1973 May-Jun       Impact factor: 2.070

7.  Pharmacokinetic studies on flupenthixol and flupenthixol decanoate in man using tritium labelled compounds.

Authors:  A Jorgensen; C G Gottfries
Journal:  Psychopharmacologia       Date:  1972

8.  Radioimmunoassay for fluphenazine in human plasma.

Authors:  D H Wiles; M Franklin
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

9.  Methods for study of fluphenazine kinetics in man.

Authors:  R Whelpton; S H Curry
Journal:  J Pharm Pharmacol       Date:  1976-12       Impact factor: 3.765

10.  ESTERS OF 4-(3-(2-(TRIFLUOROMETHYL)PHENOTHIAZIN-10-YL)PROPYL)-1-PIPERAZINEUETHANOL AS LONG-ACTING TRANQUILIZING AGENTS. SYNTHESIS OF 4-(3-(2-(TRIFLUOROMETHYL)-PHENOTHIAZIN-10-YL)PROPYL)-1-PIPERAZINEUETHANOL-ETHYL-C14 AND ITS ESTER WITH HEPTANOIC ACID. 3.

Authors:  H L YALE; F SOWINSKI; A I COHEN
Journal:  J Med Chem       Date:  1963-07       Impact factor: 7.446

View more
  25 in total

1.  Studies on the mechanism of absorption of depot neuroleptics: fluphenazine decanoate in sesame oil.

Authors:  J P Luo; J W Hubbard; K K Midha
Journal:  Pharm Res       Date:  1997-08       Impact factor: 4.200

Review 2.  Improving the prediction of the brain disposition for orally administered drugs using BDDCS.

Authors:  Fabio Broccatelli; Caroline A Larregieu; Gabriele Cruciani; Tudor I Oprea; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2011-12-21       Impact factor: 15.470

Review 3.  The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.

Authors:  Sofia Brissos; Miguel Ruiz Veguilla; David Taylor; Vicent Balanzá-Martinez
Journal:  Ther Adv Psychopharmacol       Date:  2014-10

Review 4.  Pharmacokinetics of long-acting injectable neuroleptic drugs: clinical implications.

Authors:  S R Marder; J W Hubbard; T Van Putten; K K Midha
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.

Authors:  A Viala; B Ba; A Durand; F Gouezo; N Hou; A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 6.  Clinical pharmacokinetics of the depot antipsychotics.

Authors:  M W Jann; L Ereshefsky; S R Saklad
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

7.  Pharmacokinetics of haloperidol and fluphenazine decanoates in chronic schizophrenia.

Authors:  D H Wiles; R G McCreadie; A Whitehead
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

8.  Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.

Authors:  A Viala; N Hou; B Ba; A Durand; H Dufour; N D'Agostino; C Berda; A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Variation in oro-facial tardive dyskinesia during depot antipsychotic drug treatment.

Authors:  T R Barnes; D H Wiles
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Clinical pharmacology of prochlorperazine in healthy young males.

Authors:  A O Isah; M D Rawlins; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.